Showing 241-260 of 646 for: Cochrane Systematic Reviews > Psychiatric and substance abuse 
- Group behaviour therapy programmes for smoking cessation
Cochrane Systematic Reviews, 16-Feb-2009
Group therapy offers individuals the opportunity to learn behavioural techniques for smoking cessation, and to provide each other with mutual support.
- Habit retraining for the management of urinary incontinence in adults
Cochrane Systematic Reviews, 6-Sep-2009
Habit retraining is a form of toileting assistance given by a caregiver to adults with urinary incontinence. It involves the identification of an incontinent person's natural voiding pattern and the development of an individualised toileting schedule, whi
- Haloperidol alone or in combination for acute mania
Cochrane Systematic Reviews, 12-May-2009
The main objectives in treating mania are to control dangerous behaviour, reduce suicide, produce appropriate acute sedation and shorten the episode of mood disturbance. Among different drugs, haloperidol has for many years been used in treating psychotic
- Haloperidol dose for the acute phase of schizophrenia
Cochrane Systematic Reviews, 7-Aug-2013
Haloperidol is a benchmark, accessible antipsychotic drug against which the effects of newer treatments are gauged.
- Haloperidol for agitation in dementia
Cochrane Systematic Reviews, 12-Apr-2012
Agitation occurs in up to 70% of demented patients. Haloperidol has been used for decades to control agitation in dementia, but its effectiveness remains unclear. Previous meta-analyses examined only English language publications or compared haloperidol w
- Haloperidol plus promethazine for psychosis-induced aggression
Cochrane Systematic Reviews, 4-Oct-2011
Health services often manage agitated or violent people, and for emergency psychiatric services such behaviour is particularly prevalent (10%). The drugs used in this situation should ensure that the person swiftly and safely regains composure.
- Haloperidol versus chlorpromazine for schizophrenia
Cochrane Systematic Reviews, 31-Jan-2013
Chlorpromazine and haloperidol are benchmark antipsychotic drugs. Both are said to be equally effective when used at equivalent doses, but have different side-effect profiles.
- Haloperidol versus placebo for schizophrenia
Cochrane Systematic Reviews, 5-Nov-2013
Haloperidol was developed in the late 1950s for use in the field of anaesthesia. Research subsequently demonstrated effects on hallucinations, delusions, aggressiveness, impulsiveness and states of excitement and led to the introduction of haloperidol as
- Healthcare financing systems for increasing the use of tobacco dependence treatment
Cochrane Systematic Reviews, 16-May-2012
We hypothesized that provision of financial assistance for smokers trying to quit, or reimbursement of their care providers, could lead to an increased rate of successful quit attempts.
- Heroin maintenance for chronic heroin-dependent individuals
Cochrane Systematic Reviews, 18-Apr-2012
Several types of medications have been used for stabilizing heroin users: Methadone, Buprenorphine and levo-alpha-acetyl-methadol (LAAM.) The present review focuses on the prescription of heroin to heroin-dependent individuals.
- High feedback versus low feedback of prenatal ultrasound for reducing maternal anxiety and improving maternal health behaviour in pregnancy
Cochrane Systematic Reviews, 4-Aug-2015
Prenatal ultrasound is one of many techniques used in screening and diagnosis. It gives parents instant access to the images of the fetus. Receiving information promotes knowledge and understanding, but it may also increase maternal anxiety.
- Home visits during pregnancy and after birth for women with an alcohol or drug problem
Cochrane Systematic Reviews, 1-Dec-2011
One potential method of improving outcome for pregnant or postpartum women with a drug or alcohol problem is with home visits.
- Homeopathy for attention deficit/hyperactivity disorder or hyperkinetic disorder
Cochrane Systematic Reviews, 7-Nov-2008
Homeopathy is one form of complementary/alternative medicine which is promoted as being a safe and effective form of treatment for children and adults. Within the UK homeopathy use is estimated at 1.9% of the adult population (Thomas 2004), and around 11%
- Homeopathy for dementia
Cochrane Systematic Reviews, 31-Mar-2009
Dementia is a common illness in older people and has major implications for individuals with the disease, their carers and society. A meta-analysis of population based studies in Europe found the prevalence of dementia in individuals over 65 to be 6.4%. H
- Hormone replacement therapy for cognitive function in postmenopausal women
Cochrane Systematic Reviews, 4-Jun-2008
As estrogens have been found in animal models to be associated with the maintenance and protection of brain structures, it is biologically plausible that maintaining high levels of estrogens in postmenopausal women by medication could be protective agains
- Hormone replacement therapy to maintain cognitive function in women with dementia
Cochrane Systematic Reviews, 7-Oct-2008
As estrogens have been shown to have several potentially beneficial effects on the central nervous system, it is biologically plausible that maintaining high levels of estrogens in postmenopausal women by means of estrogen replacement therapy (ERT) could
- Huperzine A for Alzheimer's disease
Cochrane Systematic Reviews, 3-Nov-2008
Alzheimer's disease (AD) has become a major public health problem around the world due to its increasing prevalence, long duration, caregiver burden, and high financial cost of care. The degeneration of acetylcholine-containing neurons in the basal forebr
- Hydergine for dementia
Cochrane Systematic Reviews, 26-Mar-2009
Currently hydergine is used almost exclusively for treating patients with either dementia, or 'age-related' cognitive symptoms. Since the early 1980s there have been over a dozen more clinical trials, yet hydergine's efficacy remains uncertain. Although p
- Hydroxyzine for generalised anxiety disorder
Cochrane Systematic Reviews, 9-Nov-2010
Generalised anxiety disorder (GAD) is a common chronic long-term psychiatric disorder, particularly frequent in primary care. There are several treatment options available, both non-pharmacological (i.e. cognitive behavioral therapy) and pharmacological.
- Hyperbaric oxygen therapy for vascular dementia
Cochrane Systematic Reviews, 7-Jun-2012
Hyperbaric oxygen therapy (HBOT) has been used to treat a variety of conditions and has shown possible efficacy for treating vascular dementia (VaD) in experimental and preliminary clinical studies.
